TLR9 and cancer: To investigate the spatial distribution of pDCs, IHC staining of LILRA4 and TLR9 was performed using TMA blocks composed of 372 LUAD, and their expression in stromal immune cells and cancer cells was compared (Figures 4A–C; Online Supplemental Figure 6).